Hydroxyzine Hcl
Brand name: Hydroxyzine Hcl
Rank #342 of 500 drugs by total cost
$30.2M
Total Cost
1,474,936
Total Claims
$30.2M
Total Cost
48,865
Prescribers
$20
Cost per Claim
268,633
Beneficiaries
1,879,935
30-Day Fills
$617
Avg Cost/Provider
30
Avg Claims/Provider
About Hydroxyzine Hcl
Hydroxyzine Hcl (sold as Hydroxyzine Hcl) was prescribed 1,474,936 times by 48,865 Medicare Part D providers in 2023, costing the program $30.2M. At $20 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 339 | Sarilumab (Kevzara) | $30.5M | 6,822 |
| 340 | Dabrafenib Mesylate (Tafinlar) | $30.4M | 2,377 |
| 341 | Testosterone (Testosterone) | $30.4M | 131,549 |
| 342 | Hydroxyzine Hcl (Hydroxyzine Hcl) | $30.2M | 1,474,936 |
| 343 | Irbesartan (Irbesartan) | $30.1M | 869,928 |
| 344 | Amiodarone Hcl (Amiodarone Hcl) | $29.9M | 1,007,679 |
| 345 | Esketamine Hcl (Spravato) | $29.0M | 20,816 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology